Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-21-018738

Chief Financial Officer acquired 20,604 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Cohen Chad M Chief Financial Officer 2021-03-04 Grant or award +20,604 21,604 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Cohen Chad M Chief Financial Officer 2021-03-04 Grant or award · Stock Option (Right to Buy) +51,511 51,511 D: show line 2 in the form
Loading xslF345X03/doc4.xml…